- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about JNJ
Recent news which mentions JNJ
3 Dow Stocks You Can Confidently Buy Now and Hold Forever
February 13, 2024
From Motley Fool
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
From Motley Fool
Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
February 12, 2024
From InvestorPlace
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
February 09, 2024
From Benzinga
Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income
February 09, 2024
From InvestorPlace
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
From Benzinga
3 Dividend Stocks to Cling to This Year
February 09, 2024
From InvestorPlace
The Watch List: Is Warren Buffett Still Selling These 3 Stocks?
February 08, 2024
From InvestorPlace
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
February 08, 2024
Tickers
JNJ
From Motley Fool
7 Dividend Stocks Worth Holding for the Long Haul
February 06, 2024
From InvestorPlace
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
From InvestorPlace
New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson's Investigational Drug Meets Primary Goal In Two Studies
February 05, 2024
From Benzinga
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
From Motley Fool
7 Dividend Stocks That Pay Me More Than $500 Per Month
February 03, 2024
From Motley Fool
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
From Benzinga
The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024
January 31, 2024
From InvestorPlace
Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot
January 30, 2024
From InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
From Benzinga
Will Novo Nordisk Be a $1 Trillion Company by 2030?
January 30, 2024
From Motley Fool
Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists
January 30, 2024
From Motley Fool
From Motley Fool
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
January 29, 2024
From InvestorPlace
Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done'
January 29, 2024
From Benzinga
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
January 27, 2024
From Motley Fool
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
From Motley Fool
Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year
January 26, 2024
From InvestorPlace
Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon
January 25, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.